A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
Bellone, Stefania, Roque, Dana M., Siegel, Eric R., Buza, Natalia, Hui, Pei, Bonazzoli, Elena, Guglielmi, Adele, Zammataro, Luca, Nagarkatti, Nupur, Zaidi, Samir, Lee, Jungsoo, Silasi, Dan‐Arin, Huang, Gloria S., Andikyan, Vaagn, Damast, Shari, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Tymon‐Rosario, Joan R., Harold, Justin A., Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, Alexandrov, Ludmil B., Iwasaki, Akiko, Kong, Yong, Song, Eric, Dong, Weilai, Elvin, Julia A., Choi, Jungmin, Santin, Alessandro D.
Published in Cancer (15.03.2022)
Published in Cancer (15.03.2022)
Get full text
Journal Article
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Zhao, Siming, Choi, Murim, Overton, John D., Bellone, Stefania, Roque, Dana M., Cocco, Emiliano, Guzzo, Federica, English, Diana P., Varughese, Joyce, Gasparrini, Sara, Bortolomai, Ileana, Buza, Natalia, Hui, Pei, Abu-Khalaf, Maysa, Ravaggi, Antonella, Bignotti, Eliana, Bandiera, Elisabetta, Romani, Chiara, Todeschini, Paola, Tassi, Renata, Zanotti, Laura, Carrara, Luisa, Pecorelli, Sergio, Silasi, Dan-Arin, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., Rutherford, Thomas J., Stiegler, Amy L., Mane, Shrikant, Boggon, Titus J., Schlessinger, Joseph, Lifton, Richard P., Santin, Alessandro D.
Published in Proceedings of the National Academy of Sciences - PNAS (19.02.2013)
Published in Proceedings of the National Academy of Sciences - PNAS (19.02.2013)
Get full text
Journal Article
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression
Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Black, Jonathan, Predolini, Federica, Pettinella, Francesca, Masserdotti, Alice, Zammataro, Luca, Altwerger, Gary, Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
Li, Charles, Bonazzoli, Elena, Bellone, Stefania, Choi, Jungmin, Dong, Weilai, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Manzano, Aranzazu, Bianchi, Anna, Pettinella, Francesca, Manara, Paola, Lopez, Salvatore, Yadav, Ghanshyam, Riccio, Francesco, Zammataro, Luca, Zeybek, Burak, Yang-Hartwich, Yang, Buza, Natalia, Hui, Pei, Wong, Serena, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Zizioli, Valentina, Odicino, Franco, Pecorelli, Sergio, Ardighieri, Laura, Silasi, Dan-Arin, Litkouhi, Babak, Ratner, Elena, Azodi, Masoud, Huang, Gloria S, Schwartz, Peter E, Lifton, Richard P, Schlessinger, Joseph, Santin, Alessandro D
Published in Proceedings of the National Academy of Sciences - PNAS (08.01.2019)
Published in Proceedings of the National Academy of Sciences - PNAS (08.01.2019)
Get full text
Journal Article
Stem‐Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
Alvero, Ayesha B., Fu, Han‐Hsuan, Holmberg, Jennie, Visintin, Irene, Mor, Liora, Marquina, Carlos Cano, Oidtman, Jessica, Silasi, Dan‐Arin, Mor, Gil
Published in Stem cells (Dayton, Ohio) (01.10.2009)
Published in Stem cells (Dayton, Ohio) (01.10.2009)
Get full text
Journal Article
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
Zeybek, Burak, Manzano, Aranzazu, Bianchi, Anna, Bonazzoli, Elena, Bellone, Stefania, Buza, Natalia, Hui, Pei, Lopez, Salvatore, Perrone, Emanuele, Manara, Paola, Zammataro, Luca, Altwerger, Gary, Han, Chanhee, Tymon-Rosario, Joan, Menderes, Gulden, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro
Published in Scientific reports (22.01.2020)
Published in Scientific reports (22.01.2020)
Get full text
Journal Article
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer
KELLY, Michael G, ALVERO, Ayesha B, RUI CHEN, SILASI, Dan-Arin, ABRAHAMS, Vikki M, CHAN, Serena, VISINTIN, Irene, RUTHERFORD, Thomas, MOR, Gil
Published in Cancer research (Chicago, Ill.) (01.04.2006)
Published in Cancer research (Chicago, Ill.) (01.04.2006)
Get full text
Journal Article
Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells
Cocco, Emiliano, Deng, Yang, Shapiro, Erik M, Bortolomai, Ileana, Lopez, Salvatore, Lin, Ken, Bellone, Stefania, Cui, Jiajia, Menderes, Gulden, Black, Jonathan D, Schwab, Carlton L, Bonazzoli, Elena, Yang, Fan, Predolini, Federica, Zammataro, Luca, Altwerger, Gary, de Haydu, Christopher, Clark, Mitchell, Alvarenga, Julio, Ratner, Elena, Azodi, Masoud, Silasi, Dan-Arin, Schwartz, Peter E, Litkouhi, Babak, Saltzman, W Mark, Santin, Alessandro D
Published in Molecular cancer therapeutics (01.02.2017)
Published in Molecular cancer therapeutics (01.02.2017)
Get full text
Journal Article
In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
Altwerger, Gary, Bonazzoli, Elena, Bellone, Stefania, Egawa-Takata, Tomomi, Menderes, Gulden, Pettinella, Francesca, Bianchi, Anna, Riccio, Francesco, Feinberg, Jacqueline, Zammataro, Luca, Han, Chanhee, Yadav, Ghanshyam, Dugan, Katherine, Morneault, Ashley, Ponte, Jose F, Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Published in Molecular cancer therapeutics (01.05.2018)
Published in Molecular cancer therapeutics (01.05.2018)
Get full text
Journal Article
Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo
Perrone, Emanuele, Manara, Paola, Lopez, Salvatore, Bellone, Stefania, Bonazzoli, Elena, Manzano, Aranzazu, Zammataro, Luca, Bianchi, Anna, Zeybek, Burak, Buza, Natalia, Tymon‐Rosario, Joan, Altwerger, Gary, Han, Chanhee, Menderes, Gulden, Huang, Gloria S., Ratner, Elena, Silasi, Dan‐Arin, Azodi, Masoud, Hui, Pei, Schwartz, Peter E., Scambia, Giovanni, Santin, Alessandro D.
Published in Molecular oncology (01.03.2020)
Published in Molecular oncology (01.03.2020)
Get full text
Journal Article
Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer
Altwerger, Gary, Florsheim, Esther B., Menderes, Gulden, Black, Jonathan, Schwab, Carlton, Gressel, Gregory M., Nelson, Wendelin K., Carusillo, Nina, Passante, Terri, Huang, Gloria, Litkouhi, Babak, Azodi, Masoud, Silasi, Dan-Arin, Santin, Alessandro, Schwartz, Peter E., Ratner, Elena S.
Published in Journal of cancer research and clinical oncology (01.12.2018)
Published in Journal of cancer research and clinical oncology (01.12.2018)
Get full text
Journal Article
Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
Perrone, Emanuele, Lopez, Salvatore, Zeybek, Burak, Bellone, Stefania, Bonazzoli, Elena, Pelligra, Silvia, Zammataro, Luca, Manzano, Aranzazu, Manara, Paola, Bianchi, Anna, Buza, Natalia, Tymon-Rosario, Joan, Altwerger, Gary, Han, Chanhee, Menderes, Gulden, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Hui, Pei, Schwartz, Peter E, Scambia, Giovanni, Santin, Alessandro D
Published in Frontiers in oncology (12.02.2020)
Published in Frontiers in oncology (12.02.2020)
Get full text
Journal Article
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Holloway, Robert W, Thaker, Premal, Mendivil, Alberto A, Ahmad, Sarfraz, Al-Niaimi, Ahmed N, Barter, James, Beck, Tiffany, Chambers, Setsuko K, Coleman, Robert L, Crafton, Sarah M, Crane, Erin, Ramez, Eskander, Ghamande, Sharad, Graybill, Whitney, Herzog, Thomas, Indermaur, Megan Dr, John, Veena S, Landrum, Lisa, Lim, Peter C, Lucci, Joseph A, McHale, Michael, Monk, Bradley J, Moore, Kathleen Nadine, Morris, Robert, O'Malley, David M, Reid, Thomas J, Richardson, Debra, Rose, Peter G, Scalici, Jennifer M, Silasi, Dan-Arin, Tewari, Krishnansu, Wang, Edward W
Published in International journal of gynecological cancer (01.09.2023)
Published in International journal of gynecological cancer (01.09.2023)
Get full text
Journal Article
Clostridium perfringens enterotoxin C‐terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy‐resistant ovarian cancer
Cocco, Emiliano, Shapiro, Erik M., Gasparrini, Sara, Lopez, Salvatore, Schwab, Carlton L., Bellone, Stefania, Bortolomai, Ileana, Sumi, Natalia J., Bonazzoli, Elena, Nicoletti, Roberta, Deng, Yang, Saltzman, W. Mark, Zeiss, Caroline J., Centritto, Floriana, Black, Jonathan D., Silasi, Dan‐Arin, Ratner, Elena, Azodi, Masoud, Rutherford, Thomas J., Schwartz, Peter E., Pecorelli, Sergio, Santin, Alessandro D.
Published in International journal of cancer (01.12.2015)
Published in International journal of cancer (01.12.2015)
Get full text
Journal Article
Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study
Altwerger, Gary, MD, Gressel, Gregory M., MD, English, Diana P., MD, Nelson, Wendelin K., PharmD, Carusillo, Nina, PAC, Silasi, Dan-Arin, MD, Azodi, Masoud, MD, Santin, Alessandro, MD, Schwartz, Peter E., MD, Ratner, Elena S., MD
Published in Gynecologic oncology (01.01.2017)
Published in Gynecologic oncology (01.01.2017)
Get full text
Journal Article
Tubulin‐β‐III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones
Roque, Dana M., Bellone, Stefania, English, Diana P., Buza, Natalia, Cocco, Emiliano, Gasparrini, Sara, Bortolomai, Ileana, Ratner, Elena, Silasi, Dan‐Arin, Azodi, Masoud, Rutherford, Thomas J., Schwartz, Peter E., Santin, Alessandro D.
Published in Cancer (15.07.2013)
Published in Cancer (15.07.2013)
Get full text
Journal Article
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)
Glasgow, Michelle A., Yu, Herbert, Rutherford, Thomas J., Azodi, Masoud, Silasi, Dan-Arin, Santin, Alessandro D., Schwartz, Peter E.
Published in Journal of surgical oncology (01.02.2013)
Published in Journal of surgical oncology (01.02.2013)
Get full text
Journal Article
Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
Cocco, Emiliano, Lopez, Salvatore, Black, Jonathan, Bellone, Stefania, Bonazzoli, Elena, Predolini, Federica, Ferrari, Francesca, Schwab, Carlton L, Menderes, Gulden, Zammataro, Luca, Buza, Natalia, Hui, Pei, Wong, Serena, Zhao, Siming, Bai, Yalai, Rimm, David L, Ratner, Elena, Litkouhi, Babak, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Published in British journal of cancer (26.07.2016)
Published in British journal of cancer (26.07.2016)
Get full text
Journal Article